LUNG TRANSPLANT REJECTION
Clinical trials for LUNG TRANSPLANT REJECTION explained in plain language.
Never miss a new study
Get alerted when new LUNG TRANSPLANT REJECTION trials appear
Sign up with your email to follow new studies for LUNG TRANSPLANT REJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Inhaled cyclosporine aims to halt lung transplant rejection
Disease control CompletedThis Phase 3 trial tested whether adding inhaled liposomal cyclosporine A to standard care can improve lung function in 169 double lung transplant patients with chronic rejection. Participants inhaled the drug twice daily for 48 weeks. The main goal was to see if it slowed the de…
Matched conditions: LUNG TRANSPLANT REJECTION
Phase: PHASE3 • Sponsor: Zambon SpA • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Inhaled cyclosporine shows promise for lung transplant rejection
Disease control CompletedThis Phase 3 trial tested whether adding inhaled liposomal cyclosporine A to standard care helps single lung transplant patients with chronic lung rejection. 62 adults who had a single lung transplant at least a year earlier and had signs of chronic rejection took part. The study…
Matched conditions: LUNG TRANSPLANT REJECTION
Phase: PHASE3 • Sponsor: Zambon SpA • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC